Mapping snakebite risk in Ghana and Rwanda

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will analyze snakebite data from health facilities and collect household survey information in diverse environments in Ghana and Rwanda to see how spatial analysis can identify risk patterns. The project will compare data collection methods to understand their contributions to predicting snakebite risk. The work is observational and aims to improve understanding of where prevention and resources are most needed. Lead institutions include the Liverpool School of Tropical Medicine and Kumasi Centre for Collaborative Research, with site in Kumasi, Ghana.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Household Screening Questionnaire:

  o Heads of household from all selected households will be invited to participate, regardless of age or sex. If the head of household is absent, another adult from the household who can report on behalf of all household members will be invited to be interviewed.
* Snakebite Details Questionnaire:

  * All household members identified with a history of snakebite will be invited to complete this questionnaire, with the assistance/in the presence of a responsible adult if the participant is a minor. If the household member is deceased, a responsible adult from the household will be asked to complete the questionnaire as far as possible.

Exclusion Criteria:

* Household Screening Questionnaire

  * Households where the household head/a responsible adult is not present at first visit or revisit.
  * Households where the household head/responsible adult is unable or unwilling to give consent.
* Snakebite Details Questionnaire

  * Where the snakebite victim is an adult and is present: the victim is unwilling to participate
  * Where the snakebite victim is an adult and is not present: there is no responsible adult who is able to complete the questionnaire on the behalf of the victim
  * Where the snakebite victim is a minor: there is no responsible adult who is able or willing to provide consent to be interviewed or support the child to complete the questionnaire.

Where it's running

• Asante Akim South Municipal Health Directorate
  Kumasi, Ghana Recruiting

Study contacts

• Principal investigator: Robert Asampong — Liverpool School of Tropical Medicine
• Study coordinator: Robert Asampong
• Email: robert.asampong@lstmed.ac.uk
• Phone: +233243645429

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing pressure pad versus pressure bandage immobilisation for snakebite first aid in healthy adults

  This test will see if a pressure pad works as well as the standard pressure bandage at slowing the spread of a mock venom in healthy adults.

  Recruiting Townsville University Hospital · Hyde Park, Queensland · NCT07261982

• Premium-PANAF antivenom for snakebite in Ethiopia

  This study tests the safety and effectiveness of Premium-PANAF antivenom for people who have been bitten by snakes in Ethiopia.

  Recruiting Medecins Sans Frontieres, Netherlands · Ābderafī, Amhara · NCT07659002

• Feasibility test of CPAP for large airway collapse

  This study tests whether using continuous positive airway pressure (CPAP) helps people with large airway collapse who also have asthma or related conditions.

  Recruiting Liverpool School of Tropical Medicine · Liverpool · NCT07504926

• Urine Pneumococcal Antigen Test in Children with Pneumonia

  This study tests a non-invasive urine test to see if it can detect pneumococcal pneumonia and identify serotypes in children under five in Malawi.

  Recruiting Liverpool School of Tropical Medicine · Blantyre · NCT07181200

• Respiratory health and wellbeing after pulmonary tuberculosis

  See if people treated for pulmonary TB in the UK have ongoing lung problems and reduced wellbeing after finishing treatment.

  Recruiting Liverpool School of Tropical Medicine · Liverpool · NCT07178860

• Antimalarial safety in early pregnancy (first trimester)

  This trial will test whether three antimalarial medicines—dihydroartemisinin‑piperaquine, pyronaridine‑artesunate, and artemether‑lumefantrine—are safe and work well for pregnant women with uncomplicated malaria in their first trimester.

  Recruiting Phase 3 Liverpool School of Tropical Medicine · Nanoro and 2 other locations · NCT06962319

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.